BD Invests $100 Million In Nebraska Plant To Expand Insulin Syringe Manufacturing
BD (Becton, Dickinson and Company), a leading global medical technology company, today announced it is investing $100 million in its Holdrege, Neb. facility to expand capacity for its…
Read More...
Read More...
